| Financial Year |
March 31 2019 |
| Monetary Funds |
3,403,574,006.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,468,208,663.59 |
| Accounts Receivable |
2,346,607,301.72 |
| Advances to Suppliers |
105,484,983.75 |
| Other Receivables |
264,650,572.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
253,365,895.45 |
| Dividend Receivable |
-- |
| Inventories |
792,897,467.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,179,076,369.14 |
| Total Current Assets |
21,560,499,365.45 |
| Available-for-Sale Financial Asset |
200,000.00 |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
53,862,996.89 |
| Fixed Assetes |
1,116,472,164.41 |
| Under-construction Projects |
17,350,407.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
180,628,575.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
22,151,107.68 |
| Deferred Income Tax Assets |
447,125,928.50 |
| Other Non-Current Assets |
39,802,125.19 |
| Sub-Total of Non-Current Assets |
1,877,593,306.05 |
| Total Assets |
23,438,092,671.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
452,959.43 |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
752,344,775.74 |
| Employee Compensation Payable |
237,883,873.69 |
| Taxes Payable |
586,411,650.60 |
| Interest Payable |
-- |
| Dividend Payable |
9,049,503.92 |
| Other payables |
172,909,045.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,686,861,485.25 |
| Sub-Total of Current Liabilities |
12,933,667,574.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,729,438.52 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
52,146,407.86 |
| Total Liabilities |
12,985,813,982.20 |
| Paid-In Capital(Or Share Stock) |
632,487,764.00 |
| Capital Surplus |
1,345,431,079.76 |
| Surplus Reserve |
332,594,722.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,621,787,838.75 |
| Minority Stockholder's Interest |
1,522,226,189.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,930,052,500.09 |
| Owner's Equity（Stockholder's Equity） |
10,452,278,689.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,438,092,671.50 |
